151 results

A worker  outside a Merck facility in  New Jersey, US, yesterday.  The  drugmaker  will eliminate  8,500 of its 81,000 global workforce  in its latest revamp. Photograph: Emile Wamsteker/Bloomberg

Merck, taking a cue from rival drugmakers that have slashed research spending to bolster earnings, has said it plans to cut annual operating costs by(...)

‘What we are doing in the universities is to support those people in developing solutions to challenges which are coming down the line,’ says Prof Kieran Hodnett

When most of us think about medicines, it is the finished products that come to mind: the shiny tablets or capsules that come in jars and packets. We(...)

Back in the dotcom boom, when investing in any and every technology start-up seemed to be the road to fast wealth, many large corporations jumped into(...)

Amgen employs about 250 people in Dublin in two sites in Dun Laoghaire andSantry.

US pharmaceutical group Amgen is to acquire Onyx Pharmaceuticals in a $10.4 billion (€7.8bn) deal that gives Amgen access to a rapidly expanding cance(...)

The new Siemens chief executive Joe Kaeser speaks at a press-conference yesterday in Munich. Photograph: Joerg Koch/Getty Images

Siemens ousted its chief executive yesterday after a high-stakes boardroom battle at the German industrial giant.The 166-year-old company did not look(...)

China is stepping up its action against corrupt health officials but the current crackdown involving executives of Glaxo- SmithKline is the highest pr(...)

Dr Michael O’Neill (left), with Darren Cunningham: “I explained we wouldn’t have to buy labs, set up offices or anything like that. He could see it as a nice idea but asked:‘Where are the assets?"

A world away from the sprawling offices and labs of major pharmaceutical companies, Irishman Dr Michael O’Neill is busy running the pre-clinical side (...)

Regulators have fined nine drugmakers, including Denmark’s Lundbeck, a total of €146 million for blocking the supply of a cheaper anti-depressant to the market

European antitrust regulators fined nine drugmakers, including Denmark’s Lundbeck, a total of €146 million for blocking the supply of a cheaper anti-d(...)

World stock markets rallied sharply yesterday, amid hopes of further economy-boosting moves by central banks and data showing US consumer confidence a(...)

MSD Ireland (Merck Sharp & Dohme) chief executive Brian Longstreet photographed at the company’s hq in Dublin

A review panel this week decided that a revolutionary new treatment for insomnia should be approved for use – but only at the lower of two dose(...)

  • « First
  • Prev
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next
  • Last »